Immediate salbutamol responsiveness does not predict long-term benefits of indacaterol in patients with chronic obstructive pulmonary disease.
Pierre Regis BurgelVincent Le GrosLaurent DecuypèreIsabelle BourdeixThierry PerezGaëtan DesléePublished in: BMC pulmonary medicine (2017)
ClinicalTrials.gov: NCT01272362 . Date: January 5, 2011.
Keyphrases